January 9, 2018 – Ipsen Biopharmaceuticals Canada Inc. Announces Health Canada Approval of DYSPORT THERAPEUTIC™ (abobotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Children Aged Two and Older
October 14, 2015 – Ipsen Grand Opening
April 2015 – Ipsen Biopharmaceuticals expands to Canada
All media enquiries should be sent to email@example.com
Ipsen at a glance
Ipsen focuses its resources and investments on three targeted specialty care areas, organized in Franchises
Ipsen Biopharmaceuticals Canada Inc. is proud to present IPSEN CARES, our IPSEN Coverage, Access, Reimbursement & Education Support program.
Letter from the Country Manager
At Ipsen Biopharmaceuticals, our mission is to develop and deliver innovative therapies to treat serious illnesses...